Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2014; 03(02): 147-148
DOI: 10.4103/2278-330X.130492
Letters to Editor

Severe neurotoxicity due to Vinblastine in Hodgkin lymphoma

Pandalanghat Suresh
Departments of Hematology and Medical Oncology, Malignant Diseases Treatment Centre, Command Hospital (SC), Pune - 411 040, Maharashtra, India
,
Rajan Kapoor
Departments of Hematology and Medical Oncology, Malignant Diseases Treatment Centre, Command Hospital (SC), Pune - 411 040, Maharashtra, India
,
B N. Kapur
Departments of Hematology and Medical Oncology, Malignant Diseases Treatment Centre, Command Hospital (SC), Pune - 411 040, Maharashtra, India
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints


Publication History

Article published online:
31 December 2020

© 2014. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Hausheer FH. Chemotherapy-Induced peripheral neuropathy. In: Perry MC, editor. The Chemotherapy Source Book. 4 th ed. Philadelphia: Lippincott Williams and Wilkins; 2008. p. 234-42.
  • 2 Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 2006;33:15-49.
  • 3 Eric KR. Antimicrotubule agents. In: Chabner BA, editor. Cancer Chemotherapy and Biotherapy: Principles and Practices. 4 th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 241-2.
  • 4 Eichenauer DA, Engert A, Dreyling M, ESMO Guidelines Working Group. Hodgkin′s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncology 2011;22:vi55-8.
  • 5 Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, et al. National Comprehensive Cancer Network. Hodgkin lymphoma, version 2.2012.